{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T20:31:53Z","timestamp":1795033913599,"version":"4.10.2"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-62558-4","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T17:24:43Z","timestamp":1754328283000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["PROCR diminishes the efficacy of radiation by impairing T-cell-mediated antitumour immunity"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1100-6216","authenticated-orcid":false,"given":"Weipeng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanmiao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenji","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingxiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liufen","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1027-071X","authenticated-orcid":false,"given":"Yanping","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1137-9349","authenticated-orcid":false,"given":"Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8901-9239","authenticated-orcid":false,"given":"Xiaoyu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"key":"62558_CR1","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/bjc.2011.240","volume":"105","author":"KJ Harrington","year":"2011","unstructured":"Harrington, K. J. et al. Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers. Br. J. Cancer 105, 628\u2013639 (2011).","journal-title":"Br. J. Cancer"},{"key":"62558_CR2","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1146\/annurev-med-081313-121208","volume":"66","author":"M Goldstein","year":"2015","unstructured":"Goldstein, M. & Kastan, M. B. The DNA damage response: implications for tumor responses to radiation and chemotherapy. Annu Rev. Med. 66, 129\u2013143 (2015).","journal-title":"Annu Rev. Med."},{"key":"62558_CR3","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nrclinonc.2016.211","volume":"14","author":"RR Weichselbaum","year":"2017","unstructured":"Weichselbaum, R. R., Liang, H., Deng, L. & Fu, Y. X. Radiotherapy and immunotherapy: a beneficial liaison?. Nat. Rev. Clin. Oncol. 14, 365\u2013379 (2017).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"62558_CR4","first-page":"65","volume":"67","author":"FG Herrera","year":"2017","unstructured":"Herrera, F. G., Bourhis, J. & Coukos, G. Radiotherapy combination opportunities leveraging immunity for the next oncology practice. CA Cancer J. Clin. 67, 65\u201385 (2017).","journal-title":"CA Cancer J. Clin."},{"key":"62558_CR5","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/nature23470","volume":"548","author":"SM Harding","year":"2017","unstructured":"Harding, S. M. et al. Mitotic progression following DNA damage enables pattern recognition within micronuclei. Nature 548, 466\u2013470 (2017).","journal-title":"Nature"},{"key":"62558_CR6","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nature23449","volume":"548","author":"KJ Mackenzie","year":"2017","unstructured":"Mackenzie, K. J. et al. cGAS surveillance of micronuclei links genome instability to innate immunity. Nature 548, 461\u2013465 (2017).","journal-title":"Nature"},{"key":"62558_CR7","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.immuni.2014.10.019","volume":"41","author":"L Deng","year":"2014","unstructured":"Deng, L. et al. STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors. Immunity 41, 843\u2013852 (2014).","journal-title":"Immunity"},{"key":"62558_CR8","doi-asserted-by":"publisher","unstructured":"Guan, J. et al. MLH1 deficiency-triggered DNA hyperexcision by exonuclease 1 activates the cGAS-STING pathway. Cancer Cell 39, https:\/\/doi.org\/10.1016\/j.ccell.2020.11.004 (2021).","DOI":"10.1016\/j.ccell.2020.11.004"},{"key":"62558_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36523-y","volume":"14","author":"JY Li","year":"2023","unstructured":"Li, J. Y. et al. TRIM21 inhibits irradiation-induced mitochondrial DNA release and impairs antitumour immunity in nasopharyngeal carcinoma tumour models. Nat. Commun. 14, 865 (2023).","journal-title":"Nat. Commun."},{"key":"62558_CR10","doi-asserted-by":"publisher","first-page":"105228","DOI":"10.1016\/j.ebiom.2024.105228","volume":"106","author":"E Domingo","year":"2024","unstructured":"Domingo, E. et al. Identification and validation of a machine learning model of complete response to radiation in rectal cancer reveals immune infiltrate and TGF\u03b2 as key predictors. EBioMedicine 106, 105228 (2024).","journal-title":"EBioMedicine"},{"key":"62558_CR11","doi-asserted-by":"publisher","first-page":"101151","DOI":"10.1016\/j.xcrm.2023.101151","volume":"4","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. CD39 inhibition and VISTA blockade may overcome radiotherapy resistance by targeting exhausted CD8+ T cells and immunosuppressive myeloid cells. Cell Rep. Med. 4, 101151 (2023).","journal-title":"Cell Rep. Med."},{"key":"62558_CR12","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrc.2016.18","volume":"16","author":"M Baumann","year":"2016","unstructured":"Baumann, M. et al. Radiation oncology in the era of precision medicine. Nat. Rev. Cancer 16, 234\u2013249 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"62558_CR13","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.1093\/nar\/gkh696","volume":"32","author":"TB Salmon","year":"2004","unstructured":"Salmon, T. B., Evert, B. A., Song, B. & Doetsch, P. W. Biological consequences of oxidative stress-induced DNA damage in Saccharomyces cerevisiae. Nucleic Acids Res. 32, 3712\u20133723 (2004).","journal-title":"Nucleic Acids Res."},{"key":"62558_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20839-0","volume":"12","author":"I Hwang","year":"2021","unstructured":"Hwang, I. et al. Cellular stress signaling activates type-I IFN response through FOXO3-regulated lamin posttranslational modification. Nat. Commun. 12, 640 (2021).","journal-title":"Nat. Commun."},{"key":"62558_CR15","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nrd4002","volume":"12","author":"C Gorrini","year":"2013","unstructured":"Gorrini, C., Harris, I. S. & Mak, T. W. Modulation of oxidative stress as an anticancer strategy. Nat. Rev. Drug Discov. 12, 931\u2013947 (2013).","journal-title":"Nat. Rev. Drug Discov."},{"key":"62558_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.stem.2010.12.012","volume":"8","author":"C Blanpain","year":"2011","unstructured":"Blanpain, C., Mohrin, M., Sotiropoulou, P. A. & Passegue, E. DNA-damage response in tissue-specific and cancer stem cells. Cell Stem Cell 8, 16\u201329 (2011).","journal-title":"Cell Stem Cell"},{"key":"62558_CR17","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/jcp.22764","volume":"227","author":"CI Kobayashi","year":"2012","unstructured":"Kobayashi, C. I. & Suda, T. Regulation of reactive oxygen species in stem cells and cancer stem cells. J. Cell. Physiol. 227, 421\u2013430 (2012).","journal-title":"J. Cell. Physiol."},{"key":"62558_CR18","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/s41422-019-0225-9","volume":"29","author":"D Wang","year":"2019","unstructured":"Wang, D. et al. Protein C receptor is a therapeutic stem cell target in a distinct group of breast cancers. Cell Res. 29, 832\u2013845 (2019).","journal-title":"Cell Res."},{"key":"62558_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41392-021-00866-z","volume":"7","author":"P Zhang","year":"2022","unstructured":"Zhang, P. et al. Protein C receptor maintains cancer stem cell properties via activating lipid synthesis in nasopharyngeal carcinoma. Signal Transduct. Target Ther. 7, 46 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"62558_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29137-3","volume":"13","author":"N Jiang","year":"2022","unstructured":"Jiang, N. et al. Fatty acid oxidation fuels glioblastoma radioresistance with CD47-mediated immune evasion. Nat. Commun. 13, 1511 (2022).","journal-title":"Nat. Commun."},{"key":"62558_CR21","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s41568-021-00388-4","volume":"21","author":"AJ Hoy","year":"2021","unstructured":"Hoy, A. J., Nagarajan, S. R. & Butler, L. M. Tumour fatty acid metabolism in the context of therapy resistance and obesity. Nat. Rev. Cancer 21, 753\u2013766 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"62558_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","volume":"31","author":"MT Snaebjornsson","year":"2020","unstructured":"Snaebjornsson, M. T., Janaki-Raman, S. & Schulze, A. Greasing the wheels of the cancer machine: the role of lipid metabolism in cancer. Cell Metab. 31, 62\u201376 (2020).","journal-title":"Cell Metab."},{"key":"62558_CR23","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nrc3958","volume":"15","author":"HE Barker","year":"2015","unstructured":"Barker, H. E., Paget, J. T., Khan, A. A. & Harrington, K. J. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat. Rev. Cancer 15, 409\u2013425 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"62558_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41568-020-0246-1","volume":"20","author":"M McLaughlin","year":"2020","unstructured":"McLaughlin, M. et al. Inflammatory microenvironment remodelling by tumour cells after radiotherapy. Nat. Rev. Cancer 20, 203\u2013217 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"62558_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21804-1","volume":"12","author":"MH Hung","year":"2021","unstructured":"Hung, M. H. et al. Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma. Nat. Commun. 12, 1455 (2021).","journal-title":"Nat. Commun."},{"key":"62558_CR26","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1016\/j.immuni.2023.11.002","volume":"56","author":"T Taifour","year":"2023","unstructured":"Taifour, T. et al. The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancer. Immunity 56, 2755\u20132772.e2758 (2023).","journal-title":"Immunity"},{"key":"62558_CR27","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.ccr.2012.04.024","volume":"21","author":"Y Pylayeva-Gupta","year":"2012","unstructured":"Pylayeva-Gupta, Y., Lee, K. E., Hajdu, C. H., Miller, G. & Bar-Sagi, D. Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. Cancer Cell 21, 836\u2013847 (2012).","journal-title":"Cancer Cell"},{"key":"62558_CR28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/cvr\/cvq076","volume":"86","author":"AR Brasier","year":"2010","unstructured":"Brasier, A. R. The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc. Res. 86, 211\u2013218 (2010).","journal-title":"Cardiovasc. Res."},{"key":"62558_CR29","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/nrm2509","volume":"9","author":"R Anjum","year":"2008","unstructured":"Anjum, R. & Blenis, J. The RSK family of kinases: emerging roles in cellular signalling. Nat. Rev. Mol. Cell Biol. 9, 747\u2013758 (2008).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"62558_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110548","volume":"38","author":"C Liu","year":"2022","unstructured":"Liu, C. et al. Procr functions as a signaling receptor and is essential for the maintenance and self-renewal of mammary stem cells. Cell Rep. 38, 110548 (2022).","journal-title":"Cell Rep."},{"key":"62558_CR31","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1074\/jbc.M117.814046","volume":"293","author":"D Wang","year":"2018","unstructured":"Wang, D. et al. Protein C receptor stimulates multiple signaling pathways in breast cancer cells. J. Biol. Chem. 293, 1413\u20131424 (2018).","journal-title":"J. Biol. Chem."},{"key":"62558_CR32","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.molcel.2020.09.021","volume":"80","author":"S Bresson","year":"2020","unstructured":"Bresson, S. et al. Stress-induced translation inhibition through rapid displacement of scanning initiation factors. Mol. Cell 80, 470\u2013484.e478 (2020).","journal-title":"Mol. Cell"},{"key":"62558_CR33","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4161\/auto.5190","volume":"4","author":"WX Ding","year":"2008","unstructured":"Ding, W. X. & Yin, X. M. Sorting, recognition and activation of the misfolded protein degradation pathways through macroautophagy and the proteasome. Autophagy 4, 141\u2013150 (2008).","journal-title":"Autophagy"},{"key":"62558_CR34","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.molcel.2011.07.039","volume":"44","author":"G Matsumoto","year":"2011","unstructured":"Matsumoto, G., Wada, K., Okuno, M., Kurosawa, M. & Nukina, N. Serine 403 phosphorylation of p62\/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins. Mol. Cell 44, 279\u2013289 (2011).","journal-title":"Mol. Cell"},{"key":"62558_CR35","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.molcel.2013.08.003","volume":"51","author":"Y Ichimura","year":"2013","unstructured":"Ichimura, Y. et al. Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. Mol. Cell 51, 618\u2013631 (2013).","journal-title":"Mol. Cell"},{"key":"62558_CR36","doi-asserted-by":"publisher","unstructured":"S\u00e1nchez-Mart\u00edn, P. & Komatsu, M. p62\/SQSTM1\u2014steering the cell through health and disease. J. Cell Sci. 131, https:\/\/doi.org\/10.1242\/jcs.222836 (2018).","DOI":"10.1242\/jcs.222836"},{"key":"62558_CR37","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41590-019-0561-4","volume":"21","author":"ME Rodriguez-Ruiz","year":"2020","unstructured":"Rodriguez-Ruiz, M. E., Vitale, I., Harrington, K. J., Melero, I. & Galluzzi, L. Immunological impact of cell death signaling driven by radiation on the tumor microenvironment. Nat. Immunol. 21, 120\u2013134 (2020).","journal-title":"Nat. Immunol."},{"key":"62558_CR38","doi-asserted-by":"publisher","unstructured":"Ji, D. et al. Combination of radiotherapy and suppression of Tregs enhances abscopal antitumor effect and inhibits metastasis in rectal cancer. J Immunother. Cancer 8, https:\/\/doi.org\/10.1136\/jitc-2020-000826 (2020).","DOI":"10.1136\/jitc-2020-000826"},{"key":"62558_CR39","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1158\/0008-5472.CAN-12-3981","volume":"73","author":"J Xu","year":"2013","unstructured":"Xu, J. et al. CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer. Cancer Res. 73, 2782\u20132794 (2013).","journal-title":"Cancer Res."},{"key":"62558_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","volume":"39","author":"DS Chen","year":"2013","unstructured":"Chen, D. S. & Mellman, I. Oncology meets immunology: the cancer-immunity cycle. Immunity 39, 1\u201310 (2013).","journal-title":"Immunity"},{"key":"62558_CR41","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.immuni.2023.09.005","volume":"56","author":"JR Giles","year":"2023","unstructured":"Giles, J. R., Globig, A. M., Kaech, S. M. & Wherry, E. J. CD8(+) T cells in the cancer-immunity cycle. Immunity 56, 2231\u20132253 (2023).","journal-title":"Immunity"},{"key":"62558_CR42","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi, O. & Akira, S. Pattern recognition receptors and inflammation. Cell 140, 805\u2013820 (2010).","journal-title":"Cell"},{"key":"62558_CR43","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.bbi.2018.02.013","volume":"70","author":"M Del Giudice","year":"2018","unstructured":"Del Giudice, M. & Gangestad, S. W. Rethinking IL-6 and CRP: why they are more than inflammatory biomarkers, and why it matters. Brain Behav. Immun. 70, 61\u201375 (2018).","journal-title":"Brain Behav. Immun."},{"key":"62558_CR44","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJM199902113400607","volume":"340","author":"C Gabay","year":"1999","unstructured":"Gabay, C. & Kushner, I. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340, 448\u2013454 (1999).","journal-title":"N. Engl. J. Med"},{"key":"62558_CR45","first-page":"710","volume":"131","author":"N Maruo","year":"1992","unstructured":"Maruo, N., Morita, I., Shirao, M. & Murota, S. IL-6 increases endothelial permeability in vitro. Endocrinology 131, 710\u2013714 (1992).","journal-title":"Endocrinology"},{"key":"62558_CR46","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/368339a0","volume":"368","author":"M Kopf","year":"1994","unstructured":"Kopf, M. et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368, 339\u2013342 (1994).","journal-title":"Nature"},{"key":"62558_CR47","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","volume":"15","author":"DE Johnson","year":"2018","unstructured":"Johnson, D. E., O\u2019Keefe, R. A. & Grandis, J. R. Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nat. Rev. Clin. Oncol. 15, 234\u2013248 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"62558_CR48","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/nrc3818","volume":"14","author":"H Yu","year":"2014","unstructured":"Yu, H., Lee, H., Herrmann, A., Buettner, R. & Jove, R. Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat. Rev. Cancer 14, 736\u2013746 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"62558_CR49","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ccell.2022.04.004","volume":"40","author":"Y Hailemichael","year":"2022","unstructured":"Hailemichael, Y. et al. Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity. Cancer Cell 40, 509\u2013523.e506 (2022).","journal-title":"Cancer Cell"},{"key":"62558_CR50","doi-asserted-by":"publisher","unstructured":"Harbour, S. N. et al. T(H)17 cells require ongoing classic IL-6 receptor signaling to retain transcriptional and functional identity. Sci. Immunol. 5, https:\/\/doi.org\/10.1126\/sciimmunol.aaw2262 (2020).","DOI":"10.1126\/sciimmunol.aaw2262"},{"key":"62558_CR51","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/ni1488","volume":"8","author":"L Zhou","year":"2007","unstructured":"Zhou, L. et al. IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8, 967\u2013974 (2007).","journal-title":"Nat. Immunol."},{"key":"62558_CR52","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1002\/eji.201040391","volume":"40","author":"A Kimura","year":"2010","unstructured":"Kimura, A. & Kishimoto, T. IL-6: regulator of Treg\/Th17 balance. Eur. J. Immunol. 40, 1830\u20131835 (2010).","journal-title":"Eur. J. Immunol."},{"key":"62558_CR53","doi-asserted-by":"publisher","first-page":"100878","DOI":"10.1016\/j.xcrm.2022.100878","volume":"4","author":"MA Huseni","year":"2023","unstructured":"Huseni, M. A. et al. CD8(+) T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy. Cell Rep. Med. 4, 100878 (2023).","journal-title":"Cell Rep. Med"},{"key":"62558_CR54","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ccell.2018.02.005","volume":"33","author":"Y Liu","year":"2018","unstructured":"Liu, Y. et al. Tumor-repopulating cells induce PD-1 expression in CD8(+) T cells by transferring kynurenine and AhR activation. Cancer Cell 33, 480\u2013494.e487 (2018).","journal-title":"Cancer Cell"},{"key":"62558_CR55","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41568-021-00366-w","volume":"21","author":"D Bayik","year":"2021","unstructured":"Bayik, D. & Lathia, J. D. Cancer stem cell-immune cell crosstalk in tumour progression. Nat. Rev. Cancer 21, 526\u2013536 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"62558_CR56","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41571-019-0293-2","volume":"17","author":"JA Clara","year":"2020","unstructured":"Clara, J. A., Monge, C., Yang, Y. & Takebe, N. Targeting signalling pathways and the immune microenvironment of cancer stem cells\u2014a clinical update. Nat. Rev. Clin. Oncol. 17, 204\u2013232 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"62558_CR57","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1083\/jcb.200507002","volume":"171","author":"G Bj\u00f8rk\u00f8y","year":"2005","unstructured":"Bj\u00f8rk\u00f8y, G. et al. p62\/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J. Cell Biol. 171, 603\u2013614 (2005).","journal-title":"J. Cell Biol."},{"key":"62558_CR58","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4161\/auto.7.3.14487","volume":"7","author":"T Johansen","year":"2011","unstructured":"Johansen, T. & Lamark, T. Selective autophagy mediated by autophagic adapter proteins. Autophagy 7, 279\u2013296 (2011).","journal-title":"Autophagy"},{"key":"62558_CR59","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41392-021-00581-9","volume":"6","author":"J Wu","year":"2021","unstructured":"Wu, J. et al. Cyst(e)ine in nutrition formulation promotes colon cancer growth and chemoresistance by activating mTORC1 and scavenging ROS. Signal Transduct. Target Ther. 6, 188 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"62558_CR60","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.1016\/j.cell.2021.06.028","volume":"184","author":"CL Evavold","year":"2021","unstructured":"Evavold, C. L. et al. Control of gasdermin D oligomerization and pyroptosis by the Ragulator-Rag-mTORC1 pathway. Cell 184, 4495\u20134511.e4419 (2021).","journal-title":"Cell"},{"key":"62558_CR61","doi-asserted-by":"publisher","unstructured":"Liu, Y. et al. Gasdermin E-mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome. Sci. Immunol. 5, https:\/\/doi.org\/10.1126\/sciimmunol.aax7969 (2020).","DOI":"10.1126\/sciimmunol.aax7969"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62558-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62558-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62558-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T14:13:28Z","timestamp":1757340808000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62558-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["62558"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-62558-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"30 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7145"}}